Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Breast Cancer Cell Lines”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 7 of 0 results

Not applicableStudy completedNCT00898014
What this trial is testing

Blood Levels of Tumor Cells in Predicting Response in Patients Receiving First-Line Chemotherapy for Stage IV Breast Cancer

Who this might be right for
Breast Cancer
Institut Curie 216
Not applicableActive Not RecruitingNCT05703269
What this trial is testing

Comparing Single vs Multiple Dose Radiation for Cancer Patients With Brain Metastasis and Receiving Immunotherapy

Who this might be right for
NSCLCRenal Cell CarcinomaBreast Carcinoma+5 more
Wake Forest University Health Sciences 58
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06849492
What this trial is testing

HIM Typing Guides the Treatment of Advanced First-Line Triple-Negative Breast Cancer

Who this might be right for
Advanced Triple Negative Breast Cancer
Fudan University 120
Testing effectiveness (Phase 2)Looking for participantsNCT06690840
What this trial is testing

Atezolizumab and Chemotherapy Treatment as T-cell Activators in Metastatic Triple Negative Breast Cancer Patients

Who this might be right for
Triple Negative Breast Cancer
European Institute of Oncology 45
Testing effectiveness (Phase 2)Ended earlyNCT04191135
What this trial is testing

Study of Olaparib Plus Pembrolizumab Versus Chemotherapy Plus Pembrolizumab After Induction With First-Line Chemotherapy Plus Pembrolizumab in Triple Negative Breast Cancer (TNBC) (MK-7339-009/KEYLYNK-009)

Who this might be right for
Triple Negative Breast Neoplasms
Merck Sharp & Dohme LLC 462
Testing effectiveness (Phase 2)Ended earlyNCT02183805
What this trial is testing

Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Metastatic Triple-negative Breast Cancer

Who this might be right for
Carcinoma Breast Stage IV
Sun Yat-sen University 6
Early research (Phase 1)UnknownNCT00715832
What this trial is testing

A Phase I Cancer Vaccine Study for Patients With Metastatic Breast Cancer

Who this might be right for
Metastatic Breast Cancer
Southern Cancer Center 25